fibrinogen has been researched along with Peripheral Vascular Diseases in 100 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (1.00) | 18.7374 |
1990's | 29 (29.00) | 18.2507 |
2000's | 62 (62.00) | 29.6817 |
2010's | 7 (7.00) | 24.3611 |
2020's | 1 (1.00) | 2.80 |
Authors | Studies |
---|---|
Doelare, SAN; Ebben, HP; Ergin, K; Hoksbergen, AWJ; Jongkind, V; Lely, RJ; Oukrich, S; Wiersema, AM; Yeung, KK | 1 |
Acin, F; Bleda, S; De Haro, J; Esparza, L; López de Maturana, I; Varela, C | 1 |
Allison, MA; Callas, PW; Criqui, MH; Cushman, M | 1 |
Dalgård, C; de Maat, MP; Enghusen-Poulsen, H; Hørder, M; Jonung, T; Morrow, JD; Nielsen, F | 1 |
Baumgartner, I; Diehm, N; Dörffler-Melly, J; Husmann, M; Kalka, C; Silvestro, A | 1 |
Bartlett, JW; De Stavola, BL; Meade, TW | 1 |
Carcaillon, L; Dartigues, JF; Ducimetière, P; Gaussem, P; Giroud, M; Ritchie, K; Scarabin, PY | 1 |
Acsády, G; Selmeci, L; Seres, L; Soós, P; Székely, M | 1 |
Azuma, K; Ebina, T; Hirawa, N; Mitsuhashi, H; Mochida, Y; Nakazawa, I; Sugano, T; Tamura, K; Toya, Y; Tsurumi-Ikeya, Y; Uchino, K; Umemura, S; Wakui, H | 1 |
Raabe, RD | 1 |
Emich-Widera, E; Kopyta, I; Marszał, E; Sarecka-Hujar, B; Zak, I | 1 |
Dhangana, R; Murphy, TP; Pencina, MJ; Zafar, AM | 1 |
Clore, J; Garvey, WT; Hunter, SJ; Jenkins, AJ; Klein, RL; Semler, AJ; Zheng, D | 1 |
Ducobu, J; Ledent, T; Lefebvre, P | 1 |
Chan, C; Criqui, MH; Fornage, M; Green, D; Greenland, P; Guralnik, JM; Liu, K; Martin, G; McDermott, MM; Pearce, WH; Quann, M; Ridker, PM; Rifai, N; Schneider, JR; Taylor, L | 1 |
Anthony, JP; Borsa, JJ; Burkart, DJ; Thurlo, SR | 1 |
Bachoo, P; Brittenden, J; Cassar, K; Ford, I; Greaves, M | 1 |
Cafferata, HT; Chow, BK; DePalma, RG; Hall, MR; Hayes, VW; Mohammadpour, HA; Zacharski, LR | 1 |
Chan, C; Criqui, MH; Green, D; Greenland, P; Guralnik, JM; Liu, K; McDermott, MM; Pearce, WH; Ridker, PM; Rifai, N; Schneider, JR; Taylor, L | 1 |
Brevetti, G; Bucur, R; Di Donato, A; Di Giacomo, S; Schiano, V; Scopacasa, F; Silvestro, A | 1 |
Budinsky, A; Doweik, L; Maca, T; Minar, E; Sabeti, S; Schillinger, M | 1 |
Chandler, WL; Hoffer, EK; Nicholls, SC | 1 |
Chung, NA; Lip, GY; Makin, AJ; Silverman, SH | 1 |
INGRAM, GI | 1 |
Connor, JM; Cooke, A; Fowkes, FG; Lee, AJ; Lowe, GD; Rumley, A; Smith, FB | 1 |
Biro, F; Kuegler, C; Michler, E; Rudofsky, G; Strubel, G | 1 |
Amighi, J; Exner, M; Minar, E; Mlekusch, W; Muellner, M; Rumpold, H; Sabeti, S; Schillinger, M; Wagner, O | 1 |
Brevetti, G; Oliva, G; Ruocco, A; Schiano, V; Scopacasa, F; Silvestro, A; Zincarelli, C | 1 |
Hull, JE; Hull, MK; Urso, JA | 1 |
Homer-Vaniasinkam, S; Naseem, KM; Nicolaou, A; Riba, R; Troxler, M | 1 |
Erlinger, TP; Selvin, E | 1 |
Chan, C; Criqui, MH; Ferrucci, L; Green, D; Greenland, P; Guralnik, JM; Liu, K; McDermott, MM; Oskin, SI; Pearce, WH; Ridker, PM; Schneider, JR; Taylor, LM | 1 |
Kobayashi, S; Maesato, K; Moriya, H; Ohtake, T; Okamoto, K | 1 |
Brancati, FL; Folsom, AR; Hirsch, AT; Pankow, JS; Selvin, E; Wattanakit, K; Weatherley, BD | 1 |
Criqui, MH; Guallar, E; Lima, JA; Nasir, K; Navas-Acien, A | 1 |
Albay, M; Bandinelli, S; Corsi, A; Ferrucci, L; Guralnik, JM; Macchi, C; McDermott, MM | 1 |
Borozanov, V; Bosevski, M; Kostoska, S; Tosev, S | 1 |
Cheng, SW; Cheuk, BL; Cheung, GC; Lau, SS | 1 |
Chen, J; He, J; Muntner, P; Sutton-Tyrrell, K; Wildman, RP | 1 |
Chin-Dusting, J; Dart, AM; Jackson, S; Kling, D; Kulkarni, S; Woollard, KJ | 1 |
Fowkes, FG; Lee, AJ; Lowe, GD; Murray, GD; Price, JF; Rumley, A; Smith, FB; Tzoulaki, I | 1 |
Dippel, EJ; Kapalis, MJ; Kirchner, HL; Lemke, JH; Palabrica, T; Robken, J; Shammas, NW; Takes, V | 1 |
Dimitroulis, D; Kakisis, JD; Kaperonis, EA; Kostakis, AG; Liapis, CD; Papavassiliou, VG; Perrea, D | 1 |
Bevelacqua, V; Bevelacqua, Y; Libra, M; Malaponte, G; Mazzarino, MC; Navolanic, PM; Polesel, J; Signorelli, SS; Stivala, F; Talamini, R | 1 |
Akaba, N; Ishimaru, S; Iwai, T; Shigematsu, H; Tsuchida, H; Umezu, S | 1 |
Hiramoto, JS; Lane, JS; Lane, KT; Messina, LM; Vittinghoff, E | 1 |
Bickel, C; Blankenberg, S; Espinola-Klein, C; Lackner, K; Munzel, T; Rupprecht, HJ; Schnabel, R | 1 |
Bounameaux, H; de Moerloose, P; Hayoz, D | 1 |
Fatourou, EM; Hamilton, G; Mikhailidis, DP; Paraskevas, KI; Seifalian, AM | 1 |
Bianchi, C; Caricato, F; Civitelli, A; Del Prato, S; Miccoli, R; Pancani, F; Pellegrini, G; Penno, G; Piaggesi, A | 1 |
Bailey, KR; Kardia, SL; Khawaja, FJ; Kullo, IJ; Mosley, TH; Turner, ST | 1 |
Baker, DM; Mikhailidis, DP; Paraskevas, KI; Vrentzos, GE | 1 |
Malaponte, G; Mazzarino, MC; Signorelli, SS; Spandidos, DA | 1 |
Brescia, P; Coratelli, P; Plantamura, M; Quaranta, D; Ramunni, A; Ria, R | 1 |
Kaplan, AA | 1 |
Schiffl, H | 1 |
Cook, NR; Creager, MA; Pradhan, AD; Ridker, PM; Rifai, N; Shrivastava, S | 1 |
Eaton, CB; Lu, B; Parker, D | 1 |
Daskalopoulos, ME; Daskalopoulou, SS; Geroulakos, G; Holloway, P; Kakkos, SK; Mayo, NE; Mikhailidis, DP; Pathmarajah, M | 1 |
Collen, D; Lacroix, H; Stockx, L; Vanderschueren, S; Verhaeghe, R; Vermylen, J; Wilms, G | 1 |
Assmann, G; Heinrich, J; Köhler, E; Schönfeld, R; Schulte, H | 1 |
Binaghi, F; Cannas, F; Caredda, E; Fronteddu, PF; Garau, P; Pitzus, F; Uras, A | 1 |
Bonino, F; Fabris, F; Macchione, C; Molaschi, M; Neirotti, M; Poli, L; Ponzetto, M | 1 |
Kauhanen, P; Lassila, R; Lepäntalo, M; Manninen, V; Peltonen, S; Saarinen, O | 1 |
Donnan, PT; Fowkes, FG; Housley, E; Lowe, GD; Rumley, A; Rumley, AG; Smith, FB | 1 |
Catapano, G; Di Bello, V; Ferrari, M; Giusti, C; Materazzi, F; Melillo, E; Mosca, F; Pedrinelli, R; Santoro, G; Talarico, L | 1 |
Dawes, J; Donnan, PT; Fowkes, FG; Housley, E; Lennie, SE; Lowe, GD | 1 |
Poredos, P; Zizek, B | 1 |
Castiglioni, C; Criqui, M; Longoni, A; Violi, F | 1 |
Arosio, E; Bosello, O; Ferrari, M; Guidi, GC; Lucchese, L; Prior, M | 1 |
Burgmann, H; Ehringer, H; Graninger, W; Hollenstein, U; Koppensteiner, R; Maca, T; Thalhammer, F; Zedwitz-Liebenstein, K | 1 |
Graf, J; Reininger, AJ; Reininger, CB; Schweiberer, L; Spannagl, M; Steckmeier, B | 1 |
Molcányiová, A; Tkác, I | 1 |
Lowe, GD; Woodburn, KR | 1 |
Cisar, LA; Kim, HC; Kostis, JB; Philipp, CS; Saidi, P; Wilson, AC | 1 |
Ernst, E; Koenig, W | 1 |
Fowkes, FG; Lee, AJ; Leng, GC; Lowe, GD; Rumley, A; Smith, FB | 1 |
Barbod, A; Berga, C; Diaz, J; Espinosa, A; Martin-Paredero, V; Richard, CM; Sanchez, J; Segura, J; Vadillo, J; Villaverde, C | 1 |
Cheng, SW; Lau, H; Ting, AC; Wong, J | 1 |
Fowkes, FG; Lee, AJ; Lowe, GD; Mowbray, PI; Price, JF; Rumley, A | 1 |
Connor, JM; Fowkes, FG; Lee, AJ; Lowe, GD; Rumley, A | 1 |
Coppola, L; Cozzolino, D; De Lucia, D; Gentile, S; Masi, S; Salvatore, T; Sasso, FC; Torella, R | 1 |
Beattie, DK; Davies, AH; Greenhalgh, RM; Sian, M | 1 |
Fowkes, FG; Hau, CM; Lee, AJ; Lowe, GD; Rumley, A; Smith, FB | 1 |
Jagroop, IA; Mikhailidis, DP; Milionis, HJ | 1 |
Atwal, AS; Davis, M; Hamilton, G; Jagroop, IA; Mikhailidis, DP; Nair, DR; Seifalian, AM | 1 |
Clement, DL; De Buyzere, M; Delanghe, J; Duprez, D; Langlois, M | 1 |
Budinsky, AC; Sinzinger, H; Wolfram, RM | 1 |
Assmann, G; Heinrich, J; Koehler, E; Schulte, H; Tataru, MC; von Eckardstein, A | 1 |
Ridker, PM; Rifai, N; Stampfer, MJ | 1 |
Andrioli, G; Arosio, E; De Marchi, S; Fontana, L; Gaino, S; Lechi, A; Lechi, C; Minuz, P; Prior, M; Zuliani, V | 1 |
de Gaetano, G; Donati, MB; Iacoviello, L | 1 |
Lip, GY; Makin, A; Silverman, SH | 1 |
Ascari, E; Ferrari, R; Galeazzi, G; Portera, C; Raddino, R; Sarasso, L; Scarabelli, TM; Visioli, O | 1 |
Ahmadi, R; Exner, M; Haumer, M; Minar, E; Mlekusch, W; Rumpold, H; Schillinger, M; Wagner, O | 1 |
Flavell, DM; Hawe, E; Humphries, SE; Jamshidi, Y; MacCallum, PK; Meade, TW | 1 |
Connor, JM; Donnan, PT; Fowkes, FG; Lowe, GD; Smith, FB; Wood, J | 1 |
de Bart, AC; de Knijff, P; Frants, RR; Havekes, LM; Kluft, C | 1 |
Lunetta, M; Salanitri, T | 1 |
Boschetti, C; Catalano, M; Cofrancesco, E; Cortellaro, M; de Gaetano, G; Gabrielli, L; Lombardi, B; Specchia, G; Tavazzi, L; Zanussi, C | 1 |
12 review(s) available for fibrinogen and Peripheral Vascular Diseases
Article | Year |
---|---|
[Recent progress in the "fibrinogen hypothesis"].
Topics: Biomarkers; Cardiovascular Diseases; Cerebrovascular Disorders; Diabetes Complications; Fibrinogen; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Peripheral Vascular Diseases; Risk Factors | 2003 |
Relationship of the platelet glycoprotein PlA and fibrinogen T/G+1689 polymorphisms with peripheral arterial disease and ischaemic heart disease.
Topics: Aged; Angina Pectoris; Antigens, CD; Antigens, Surface; Arterial Occlusive Diseases; Cross-Sectional Studies; Female; Fibrinogen; Humans; Intermittent Claudication; Lectins, C-Type; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; NK Cell Lectin-Like Receptor Subfamily B; Peripheral Vascular Diseases; Polymorphism, Single Nucleotide; Risk Factors; Scotland; Smoking | 2003 |
[Peripheric arteriopathy: focus in 2007].
Topics: Antifibrinolytic Agents; Atherosclerosis; Biomarkers; E-Selectin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Intercellular Adhesion Molecule-1; Peripheral Vascular Diseases; Plasminogen Activator Inhibitor 1; Risk Factors; Serine Proteinase Inhibitors; Vitamin B 6 | 2007 |
The role of established and emerging risk factors in peripheral vascular graft occlusion.
Topics: C-Reactive Protein; Cholesterol; Coronary Artery Bypass; Diabetes Mellitus; Fibrinogen; Graft Occlusion, Vascular; Homocysteine; Humans; Hypertension; Lipoprotein(a); Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Risk Factors; Smoking; Vascular Surgical Procedures | 2007 |
The role of fibrinogen and fibrinolysis in peripheral arterial disease.
Topics: Age Distribution; Aged; Atherosclerosis; Fibrinogen; Fibrinolysis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Peripheral Vascular Diseases | 2008 |
Proinflammatory circulating molecules in peripheral arterial disease.
Topics: C-Reactive Protein; Cell Adhesion Molecules; Cytokines; Diabetes Mellitus, Type 2; Fibrinogen; Humans; Inflammation Mediators; Interleukin-6; Matrix Metalloproteinases; Models, Biological; Peripheral Vascular Diseases; Polymorphism, Single Nucleotide | 2007 |
Selective fibrinogen apheresis for improvement in microvascular hemodynamics.
Topics: Blood Component Removal; Cholesterol, LDL; Fibrinogen; Hemodynamics; Humans; Microcirculation; Peripheral Vascular Diseases | 2007 |
Fibrinogen, fibrin turnover, endothelial products and vascular surgery.
Topics: Arteriosclerosis; Biomarkers; Blood Vessel Prosthesis; Fibrin; Fibrinogen; Humans; Peripheral Vascular Diseases; Plasminogen Inactivators; Thrombosis; von Willebrand Factor | 1997 |
Fibrinogen and cardiovascular risk.
Topics: Arterial Occlusive Diseases; Biomarkers; Cardiovascular Diseases; Cross-Sectional Studies; Fibrinogen; Humans; Myocardial Ischemia; Peripheral Vascular Diseases; Reference Values; Risk Factors | 1997 |
Assessment of peripheral arterial vascular disease with radionuclide techniques.
Topics: Animals; Arterial Occlusive Diseases; Blood Platelets; Fibrinogen; Humans; Immunoglobulins; Indium Radioisotopes; Lipoproteins; Monocytes; Muscles; Nuclear Medicine; Organotechnetium Compounds; Peptides; Peripheral Vascular Diseases; Porphyrins; Radiopharmaceuticals; Thallium Radioisotopes; Tomography, Emission-Computed | 2001 |
Peripheral vascular disease and Virchow's triad for thrombogenesis.
Topics: Arteries; Blood Coagulation Disorders; Blood Coagulation Factors; Fibrin Fibrinogen Degradation Products; Fibrinogen; Homocysteine; Humans; Peripheral Vascular Diseases; Regional Blood Flow; Thrombosis | 2002 |
[Clinical implications of rheology in cardiovascular diseases].
Topics: Adult; Blood Sedimentation; Blood Viscosity; Cardiovascular Diseases; Cerebrovascular Disorders; Child; Diabetic Angiopathies; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Leukemia; Leukocytes; Malaria; Middle Aged; Myocardial Infarction; Peripheral Vascular Diseases; Prospective Studies; Risk Factors; Thrombosis | 2002 |
20 trial(s) available for fibrinogen and Peripheral Vascular Diseases
Article | Year |
---|---|
Supplementation with orange and blackcurrant juice, but not vitamin E, improves inflammatory markers in patients with peripheral arterial disease.
Topics: Antioxidants; Beverages; Biomarkers; C-Reactive Protein; Citrus sinensis; Dietary Supplements; Female; Fibrinogen; Humans; Interleukin-6; Male; Middle Aged; Multivariate Analysis; Oxidative Stress; Peripheral Vascular Diseases; Ribes; Statistics, Nonparametric; Vitamin E; von Willebrand Factor | 2009 |
Successful lower extremity angioplasty improves brachial artery flow-mediated dilation in patients with peripheral arterial disease.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon; Ankle; Arterial Occlusive Diseases; Brachial Artery; C-Reactive Protein; Female; Femoral Artery; Fibrinogen; Humans; Inflammation Mediators; Intermittent Claudication; Ischemia; Leukocyte Count; Lower Extremity; Male; Middle Aged; Peripheral Vascular Diseases; Popliteal Artery; Prospective Studies; Regional Blood Flow; Time Factors; Treatment Outcome; Ultrasonography; Vasodilation | 2008 |
Sustained inhibition of oxidized low-density lipoprotein is involved in the long-term therapeutic effects of apheresis in dialysis patients.
Topics: Aged; Ankle Brachial Index; Biomarkers; Blood Component Removal; C-Reactive Protein; Cell Proliferation; Cells, Cultured; Down-Regulation; Endothelial Cells; Enzyme Activation; Female; Fibrinogen; Humans; Inflammation; Kidney Diseases; Lipoproteins, LDL; Male; Middle Aged; Nitric Oxide Synthase Type III; Peripheral Vascular Diseases; Recovery of Function; Renal Dialysis; Time Factors; Treatment Outcome; Walking | 2010 |
D-dimer, inflammatory markers, and lower extremity functioning in patients with and without peripheral arterial disease.
Topics: Aged; Ankle; Biomarkers; Brachial Artery; C-Reactive Protein; Cohort Studies; Exercise Test; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Lower Extremity; Male; Middle Aged; Peripheral Vascular Diseases; Predictive Value of Tests; Serum Amyloid A Protein; Walking | 2003 |
Cytokine signatures in atherosclerotic claudicants.
Topics: Aged; Aged, 80 and over; Aging; Arteriosclerosis; Blood Glucose; C-Reactive Protein; Cholesterol; Cytokines; Ferritins; Fibrinogen; Glycated Hemoglobin; Humans; Interleukin-10; Interleukin-2; Interleukin-6; Iron; Middle Aged; Peripheral Vascular Diseases; Phlebotomy; Tumor Necrosis Factor-alpha | 2003 |
Failure of peripheral arterial thrombolysis due to elevated plasminogen activator inhibitor type 1.
Topics: Female; Fibrinogen; Humans; Male; Peripheral Vascular Diseases; Plasminogen Activator Inhibitor 1; Risk Factors; Thrombin Time; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator; Treatment Failure; Urokinase-Type Plasminogen Activator | 2003 |
Thrombogenesis and endothelial damage/dysfunction in peripheral artery disease. Relationship to ethnicity and disease severity.
Topics: Aged; Arteries; Arteriosclerosis; Asian People; Biomarkers; Black People; Causality; Comorbidity; Endothelium, Vascular; Female; Fibrinogen; Humans; Intermittent Claudication; Male; P-Selectin; Peripheral Vascular Diseases; Risk Assessment; Risk Factors; Severity of Illness Index; Statistics as Topic; Thromboplastin; Thrombosis; United Kingdom; von Willebrand Factor; White People | 2003 |
Eptifibatide in peripheral vascular interventions: results of the Integrilin Reduces Inflammation in Peripheral Vascular Interventions (INFLAME) trial.
Topics: Aged; Aneurysm, False; Anticoagulants; Biomarkers; Dose-Response Relationship, Drug; Eptifibatide; Female; Fibrinogen; Hemorrhage; Heparin; Humans; Inflammation; Injections, Intravenous; Male; Middle Aged; Peptides; Peripheral Vascular Diseases; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombin; Time Factors; Whole Blood Coagulation Time | 2006 |
Effect of low-density lipoprotein apheresis on patients with peripheral arterial disease. Peripheral Arterial Disease LDL Apheresis Multicenter Study (P-LAS).
Topics: Aged; Aged, 80 and over; Biomarkers; Blood Pressure; Cholesterol, HDL; Cholesterol, LDL; Erythrocytes; Exercise Test; Exercise Tolerance; Female; Fibrinogen; Follow-Up Studies; Hemostasis; Humans; Hypercholesterolemia; Intermittent Claudication; Ischemia; Japan; Lower Extremity; Male; Microcirculation; Middle Aged; Peripheral Vascular Diseases; Plasmapheresis; Plethysmography; Recovery of Function; Severity of Illness Index; Spectroscopy, Near-Infrared; Treatment Outcome; Triglycerides | 2006 |
Fibrinogen apheresis in the treatment of peripheral arterial disease.
Topics: Aged; Aged, 80 and over; Blood Component Removal; Endothelium, Vascular; Exercise Tolerance; Female; Fibrinogen; Hemodynamics; Humans; Lower Extremity; Male; Microcirculation; Middle Aged; Peripheral Vascular Diseases; Skin; Treatment Outcome; Walking | 2007 |
Hemodynamic, hemorheologic, and hemocoagulative changes after treatment with picotamide in patients affected by peripheral arterial disease (PAD) of the lower limbs.
Topics: Arterial Occlusive Diseases; beta-Thromboglobulin; Blood Coagulation; Blood Viscosity; Double-Blind Method; Erythrocyte Deformability; Fibrinogen; Hemorheology; Humans; Intermittent Claudication; Male; Middle Aged; Peripheral Vascular Diseases; Photoplethysmography; Phthalic Acids; Platelet Aggregation Inhibitors | 1994 |
Relation between risk factors and cardiovascular complications in patients with peripheral vascular disease. Results from the A.D.E.P. study.
Topics: Adult; Aged; Cardiovascular Diseases; Cerebrovascular Disorders; Comorbidity; Diabetes Mellitus; Disease Susceptibility; Female; Fibrinogen; Follow-Up Studies; Humans; Hypertension; Incidence; Italy; Leukocyte Count; Logistic Models; Male; Middle Aged; Odds Ratio; Peripheral Vascular Diseases; Phthalic Acids; Platelet Aggregation Inhibitors; Prospective Studies; Receptors, Thromboxane; Risk Factors; Smoking; Vascular Surgical Procedures | 1996 |
Lipoprotein(a) and general risk factors in patients with angiographically assessed peripheral arterial disease.
Topics: Adult; Aged; Arterial Occlusive Diseases; Body Constitution; Body Mass Index; Case-Control Studies; Cholesterol; Female; Fibrinogen; Humans; Hypertension; Lipoprotein(a); Male; Middle Aged; Peripheral Vascular Diseases; Prospective Studies; Radiography; Regression Analysis; Risk Factors; Smoking | 1995 |
Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery Study.
Topics: Aged; Arterial Occlusive Diseases; Biomarkers; Blood Pressure; Blood Viscosity; Cholesterol; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Humans; Lipoproteins; Male; Middle Aged; Peripheral Vascular Diseases; Prospective Studies; Risk Factors; Smoking; Surveys and Questionnaires; United Kingdom | 1999 |
Short- and long-term treatments with iloprost in diabetic patients with peripheral vascular disease: effects on the cardiovascular risk factor plasminogen activator inhibitor type-1.
Topics: Aged; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Fasting; Female; Fibrinogen; Glycated Hemoglobin; Humans; Iloprost; Insulin; Male; Middle Aged; Peripheral Vascular Diseases; Pilot Projects; Plasminogen; Plasminogen Activator Inhibitor 1; Platelet Aggregation Inhibitors; Risk Factors; Time Factors; Treatment Outcome; Walking | 1999 |
The effect of short-term lipid lowering with atorvastatin on carotid artery intima media thickness in patients with peripheral vascular disease: a pilot study.
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Carotid Arteries; Cholesterol; Exercise Test; Female; Fibrinogen; Heptanoic Acids; Homocysteine; Humans; Male; Middle Aged; Peripheral Vascular Diseases; Pilot Projects; Pyrroles; Statistics, Nonparametric; Tunica Intima; Tunica Media; Ultrasonography | 2000 |
Vascular adhesion molecule-1 and markers of platelet function before and after a treatment with iloprost or a supervised physical exercise program in patients with peripheral arterial disease.
Topics: Aged; Arteriosclerosis; Blood Glucose; Blood Pressure; Cholesterol; Endothelium, Vascular; Exercise; Fibrinogen; Humans; Iloprost; Male; Middle Aged; Peripheral Vascular Diseases; Platelet Activation; Platelet Function Tests; Treatment Outcome; Triglycerides; Vascular Cell Adhesion Molecule-1 | 2001 |
Genetic determinants of the response to bezafibrate treatment in the lower extremity arterial disease event reduction (LEADER) trial.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Apolipoprotein C-III; Apolipoproteins C; Arterial Occlusive Diseases; Base Sequence; Bezafibrate; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Fibrinogen; Follow-Up Studies; Genetic Markers; Genetic Predisposition to Disease; Genotype; Humans; Hypolipidemic Agents; Male; Middle Aged; Molecular Sequence Data; Peripheral Vascular Diseases; Polymerase Chain Reaction; Polymorphism, Genetic; Probability; Reference Values; Sensitivity and Specificity; Treatment Outcome | 2002 |
Lowering of plasma viscosity by the oral administration of the glycosaminoglycan sulodexide in patients with peripheral vascular disease.
Topics: Administration, Oral; Adult; Blood Coagulation; Blood Viscosity; Double-Blind Method; Female; Fibrinogen; Glycosaminoglycans; Humans; Male; Middle Aged; Peripheral Vascular Diseases; Thrombosis | 1992 |
The PLAT Study: a multidisciplinary study of hemostatic function and conventional risk factors in vascular disease patients.
Topics: Aged; Antithrombin III; Arteriosclerosis; Blood Coagulation Factors; Electrocardiography; Female; Fibrinogen; Hemostasis; Humans; Intracranial Arteriosclerosis; Lipids; Male; Middle Aged; Myocardial Infarction; Peripheral Vascular Diseases; Prospective Studies; Protein C; Risk Factors; Smoking | 1991 |
68 other study(ies) available for fibrinogen and Peripheral Vascular Diseases
Article | Year |
---|---|
Major Bleeding During Thrombolytic Therapy for Acute Lower Limb Ischaemia: Value of Laboratory Tests for Clinical Decision Making, 17 Years of Experience.
Topics: Arterial Occlusive Diseases; Clinical Decision-Making; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Ischemia; Peripheral Vascular Diseases; Prospective Studies; Retrospective Studies; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome; Urokinase-Type Plasminogen Activator | 2023 |
Inflammatory burden predicts long-term outcomes in endovascular therapy in peripheral arterial disease.
Topics: Biomarkers; C-Reactive Protein; Endovascular Procedures; Fibrinogen; Follow-Up Studies; Humans; Peripheral Vascular Diseases; Prognosis; Prospective Studies; Reoperation; Risk Factors; Spain; Survival Rate; Time Factors; Vasculitis | 2013 |
Inflammation and peripheral venous disease. The San Diego Population Study.
Topics: Aged; Biomarkers; C-Reactive Protein; California; Chemokine CCL2; Cytokines; Disease Progression; E-Selectin; Female; Fibrinogen; Humans; Inflammation Mediators; Intercellular Adhesion Molecule-1; Male; Middle Aged; Peripheral Vascular Diseases; Population Groups; Vascular Cell Adhesion Molecule-1; Vascular Endothelial Growth Factor A; Veins | 2014 |
Assessing the contribution of fibrinogen in predicting risk of death in men with peripheral arterial disease.
Topics: Aged; Aged, 80 and over; Cause of Death; Death; Fibrinogen; Humans; Male; Middle Aged; Models, Statistical; Odds Ratio; Peripheral Vascular Diseases; Predictive Value of Tests; Randomized Controlled Trials as Topic; Risk; Survival Analysis | 2009 |
Elevated plasma fibrin D-dimer as a risk factor for vascular dementia: the Three-City cohort study.
Topics: Age Factors; Aged; Biomarkers; Cohort Studies; Dementia, Vascular; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Incidence; Male; Peripheral Vascular Diseases; Prospective Studies; Risk Factors; Stroke; von Willebrand Factor | 2009 |
Assay of oxidized fibrinogen reactivity (OFR) as a biomarker of oxidative stress in human plasma: the role of lysine analogs.
Topics: Adult; Aged; Aged, 80 and over; Aminocaproates; Apoprotein(a); Biomarkers; Female; Fibrinogen; Humans; Kinetics; Lysine; Male; Middle Aged; Oxidative Stress; Peripheral Vascular Diseases; Tranexamic Acid | 2010 |
Ultrasound-accelerated thrombolysis in arterial and venous peripheral occlusions: fibrinogen level effects.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Biomarkers; Combined Modality Therapy; Down-Regulation; Drug Administration Schedule; Female; Fibrinogen; Fibrinolytic Agents; Humans; Infusions, Parenteral; Male; Middle Aged; Peripheral Vascular Diseases; Radiography; Retrospective Studies; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Treatment Outcome; Ultrasonic Therapy; Vascular Patency; Venous Thrombosis; Washington; Young Adult | 2010 |
Association between lipids and fibrinogen levels and ischemic stroke in the population of the Polish children with arteriopathy and cardiac disorders.
Topics: Adolescent; Child; Cohort Studies; Comorbidity; Female; Fibrinogen; Heart Diseases; Humans; Lipid Metabolism; Male; Peripheral Vascular Diseases; Poland; Risk Factors; Stroke; Triglycerides | 2010 |
Prevalence of low ankle-brachial index, elevated plasma fibrinogen and CRP across Framingham risk categories: data from the National Health and Nutrition Examination Survey (NHANES) 1999-2004.
Topics: Adult; Aged; Ankle Brachial Index; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Chi-Square Distribution; Cross-Sectional Studies; Female; Fibrinogen; Humans; Male; Middle Aged; Nutrition Surveys; Peripheral Vascular Diseases; Prevalence; Risk Assessment; Risk Factors; Time Factors; United States; Up-Regulation | 2011 |
Fibrinogen is a marker for nephropathy and peripheral vascular disease in type 1 diabetes: studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort.
Topics: Adenine; Adult; Albuminuria; Base Sequence; Biomarkers; Cohort Studies; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; DNA Primers; Female; Fibrinogen; Guanine; Humans; Male; Peripheral Vascular Diseases; Polymorphism, Single Nucleotide; Regression Analysis | 2003 |
Thrombolysis of acute peripheral arterial and venous occlusions with tenecteplase and eptifibatide: a pilot study.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Biomarkers; Disease-Free Survival; Drug Therapy, Combination; Eptifibatide; Female; Femoral Artery; Femoral Vein; Fibrinogen; Fibrinolytic Agents; Follow-Up Studies; Hematocrit; Hemoglobins; Hemorrhage; Humans; Iliac Artery; Iliac Vein; Lower Extremity; Male; Middle Aged; Missouri; Peptides; Peripheral Vascular Diseases; Pilot Projects; Platelet Aggregation Inhibitors; Popliteal Artery; Popliteal Vein; Prospective Studies; Tenecteplase; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Treatment Outcome; Vena Cava, Inferior; Venous Thrombosis | 2003 |
Platelet activation is increased in peripheral arterial disease.
Topics: Aged; Female; Fibrinogen; Flow Cytometry; Humans; Intermittent Claudication; Ischemia; Lower Extremity; Male; Middle Aged; P-Selectin; Peripheral Vascular Diseases; Platelet Activation; Prospective Studies | 2003 |
Relation of levels of hemostatic factors and inflammatory markers to the ankle brachial index.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Pressure; Brachial Artery; C-Reactive Protein; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Inflammation Mediators; Male; Middle Aged; Peripheral Vascular Diseases; Plasminogen Activator Inhibitor 1; Plasminogen Activators; Prothrombin; Serine Proteinase Inhibitors; Serum Amyloid A Protein; Severity of Illness Index; Tissue Plasminogen Activator | 2003 |
Endothelial dysfunction in peripheral arterial disease is related to increase in plasma markers of inflammation and severity of peripheral circulatory impairment but not to classic risk factors and atherosclerotic burden.
Topics: Aged; Arteriosclerosis; Biomarkers; Blood Circulation; C-Reactive Protein; Cross-Sectional Studies; Endothelium, Vascular; Female; Fibrinogen; Humans; Male; Middle Aged; Peripheral Vascular Diseases; Risk Factors | 2003 |
Fibrinogen predicts mortality in high risk patients with peripheral artery disease.
Topics: Aged; Aged, 80 and over; Arteriosclerosis; Biomarkers; Female; Fibrinogen; Humans; Male; Middle Aged; Peripheral Vascular Diseases; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Risk Factors; Survival Rate | 2003 |
Plasma fibrinogen concentration in occlusive arterial disease.
Topics: Arterial Occlusive Diseases; Fibrin; Fibrinogen; Humans; Peripheral Vascular Diseases; Vascular Diseases | 1952 |
Influence of fibrinogen and hematocrit on the early outcome of angioplasty in patients with PAOD.
Topics: Aged; Angioplasty, Balloon; Arterial Occlusive Diseases; Diabetic Angiopathies; Female; Fibrinogen; Hematocrit; Humans; Ischemia; Male; Middle Aged; Peripheral Vascular Diseases; Treatment Outcome | 2004 |
Statin therapy improves cardiovascular outcome of patients with peripheral artery disease.
Topics: Aged; Apolipoproteins; C-Reactive Protein; Death, Sudden, Cardiac; Disease-Free Survival; Female; Fibrinogen; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Neutrophils; Peripheral Vascular Diseases; Prospective Studies; Serum Amyloid A Protein; Treatment Outcome | 2004 |
Inflammatory status and endothelial function in asymptomatic and symptomatic peripheral arterial disease.
Topics: Aged; Biomarkers; Brachial Artery; C-Reactive Protein; Case-Control Studies; Endothelium, Vascular; Female; Fibrinogen; Humans; Intercellular Adhesion Molecule-1; Interleukin-6; Male; Middle Aged; Multivariate Analysis; Peripheral Vascular Diseases; Regional Blood Flow; Vascular Cell Adhesion Molecule-1; Vasodilation | 2003 |
Reteplase with or without abciximab for peripheral arterial occlusions: efficacy and adverse events.
Topics: Abciximab; Analysis of Variance; Antibodies, Monoclonal; Arterial Occlusive Diseases; Drug Therapy, Combination; Female; Fibrinogen; Fibrinolytic Agents; Graft Occlusion, Vascular; Humans; Immunoglobulin Fab Fragments; Male; Peripheral Vascular Diseases; Recombinant Proteins; Retrospective Studies; Thrombosis; Tissue Plasminogen Activator; Treatment Outcome | 2004 |
Altered platelet reactivity in peripheral vascular disease complicated with elevated plasma homocysteine levels.
Topics: Adenosine Diphosphate; Aged; Blood Platelets; Fibrinogen; Flow Cytometry; Homocysteine; Humans; Intermittent Claudication; Middle Aged; Nitric Oxide; Nitric Oxide Donors; P-Selectin; Peripheral Vascular Diseases; Platelet Activation; S-Nitrosoglutathione; Sulfhydryl Compounds | 2004 |
Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Blood Pressure Determination; Brachial Artery; C-Reactive Protein; Comorbidity; Cross-Sectional Studies; Diabetes Mellitus; Female; Fibrinogen; Glomerular Filtration Rate; Health Surveys; Humans; Hypercholesterolemia; Hypertension; Kidney Diseases; Male; Middle Aged; Peripheral Vascular Diseases; Prevalence; Racial Groups; Risk Factors; Smoking; Tibial Arteries; United States | 2004 |
Inflammatory and thrombotic blood markers and walking-related disability in men and women with and without peripheral arterial disease.
Topics: Aged; Biomarkers; C-Reactive Protein; Cholesterol; Cross-Sectional Studies; Disability Evaluation; Female; Fibrinogen; Geriatric Assessment; Humans; Inflammation; Male; Peripheral Vascular Diseases; Serum Amyloid A Protein; Statistics, Nonparametric; Thrombosis; Walking | 2004 |
LDL-apheresis improves peripheral arterial occlusive disease with an implication for anti-inflammatory effects.
Topics: Adult; Aged; Aged, 80 and over; Arteriosclerosis; C-Reactive Protein; Chemokine CCL2; Female; Fibrinogen; Hemofiltration; Humans; Inflammation; Ischemia; Lipoproteins, LDL; Male; Middle Aged; Peripheral Vascular Diseases | 2005 |
Risk factors for peripheral arterial disease incidence in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study.
Topics: Arteriosclerosis; Cohort Studies; Coronary Artery Disease; Diabetes Complications; Female; Fibrinogen; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Peripheral Vascular Diseases; Risk Factors; Smoking; Tunica Intima | 2005 |
Relationship of monocyte count and peripheral arterial disease: results from the National Health and Nutrition Examination Survey 1999-2002.
Topics: Aged; Ankle; Atherosclerosis; Biomarkers; Blood Pressure; Brachial Artery; C-Reactive Protein; Cross-Sectional Studies; Female; Fibrinogen; Humans; Leukocyte Count; Male; Middle Aged; Monocytes; Nutrition Surveys; Peripheral Vascular Diseases; Prevalence; Risk Factors | 2005 |
Patterns of inflammation associated with peripheral arterial disease: the InCHIANTI study.
Topics: Aged; Aged, 80 and over; alpha-Macroglobulins; Biomarkers; Body Mass Index; C-Reactive Protein; Cholesterol; Comorbidity; Cytokines; Female; Fibrinogen; Health Surveys; Humans; Inflammation; Interleukin 1 Receptor Antagonist Protein; Interleukins; Italy; Male; Middle Aged; Motor Activity; Peripheral Vascular Diseases; Pulse; Sampling Studies; Serum Albumin; Sialoglycoproteins; Smoking; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2005 |
Prognostic importance of haemostatic parameters in polyarterial disease.
Topics: Aged; Coronary Artery Disease; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Peripheral Vascular Diseases; Prognosis | 2005 |
Plasma fibrinogen level: an independent risk factor for long-term survival in Chinese patients with peripheral artery disease?
Topics: Aged; Atherosclerosis; Biomarkers; Female; Fibrinogen; Hong Kong; Humans; Male; Peripheral Vascular Diseases; Risk Factors; Survival Analysis | 2005 |
Relation of inflammation to peripheral arterial disease in the national health and nutrition examination survey, 1999-2002.
Topics: Adult; Aged; Biomarkers; Blood Pressure; C-Reactive Protein; Cross-Sectional Studies; Female; Fibrinogen; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Nutrition Surveys; Odds Ratio; Peripheral Vascular Diseases; Prevalence; Retrospective Studies; Risk Factors; United States | 2005 |
Raised plasma soluble P-selectin in peripheral arterial occlusive disease enhances leukocyte adhesion.
Topics: Aged; Arterial Occlusive Diseases; Cell Adhesion; Female; Fibrinogen; Humans; Leukocytes; Male; Middle Aged; Neutrophils; P-Selectin; Peripheral Vascular Diseases | 2006 |
Hemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis: the Edinburgh Artery Study.
Topics: Aged; Arteriosclerosis; C-Reactive Protein; Disease Progression; Female; Fibrinogen; Hemostasis; Humans; Inflammation; Interleukin-6; Male; Middle Aged; Peripheral Vascular Diseases; Prognosis; Prospective Studies; Risk Assessment; Risk Factors; Surveys and Questionnaires; Time Factors | 2006 |
Inflammation and Chlamydia pneumoniae infection correlate with the severity of peripheral arterial disease.
Topics: Aged; Antibodies, Bacterial; Atherosclerosis; C-Reactive Protein; Case-Control Studies; Chlamydophila pneumoniae; Cross-Sectional Studies; Female; Fibrinogen; Humans; Inflammation Mediators; Male; Middle Aged; Peripheral Vascular Diseases; Severity of Illness Index; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2006 |
Analysis of G(-174)C IL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease.
Topics: Aged; C-Reactive Protein; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Interleukin-6; Male; Middle Aged; Peripheral Vascular Diseases; Polymorphism, Genetic; Vascular Endothelial Growth Factor A | 2006 |
Risk factors for premature peripheral vascular disease: results for the National Health and Nutritional Survey, 1999-2002.
Topics: Age of Onset; Ankle; Blood Pressure; Brachial Artery; Coronary Artery Disease; Demography; Female; Fibrinogen; Health Surveys; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Nutrition Surveys; Peripheral Vascular Diseases; Prevalence; Risk Factors; United States | 2006 |
Inflammation, atherosclerotic burden and cardiovascular prognosis.
Topics: Aged; Biomarkers; Carotid Artery Diseases; Coronary Angiography; Coronary Artery Disease; Female; Femoral Artery; Fibrinogen; Follow-Up Studies; Germany; Humans; Inflammation; Interleukin-18; Laser-Doppler Flowmetry; Male; Middle Aged; Peripheral Vascular Diseases; Predictive Value of Tests; Prognosis; Prospective Studies; Ultrasonography | 2007 |
Non-traditional cardiovascular risk factors contribute to peripheral arterial disease in patients with type 2 diabetes.
Topics: Aged; Ankle; Blood Pressure; Brachial Artery; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glycated Hemoglobin; Humans; Italy; Logistic Models; Male; Middle Aged; Peripheral Vascular Diseases; Prevalence; Pulse; Risk Factors; Smoking | 2007 |
Association of novel risk factors with the ankle brachial index in African American and non-Hispanic white populations.
Topics: Ankle; Black or African American; C-Reactive Protein; Female; Fibrinogen; Homocysteine; Humans; Linear Models; Male; Middle Aged; Peripheral Vascular Diseases; Predictive Value of Tests; Risk Factors; White People | 2007 |
Fibrinogen apheresis and peripheral vascular disease: some progress?
Topics: Blood Component Removal; Fibrinogen; Humans; Peripheral Vascular Diseases; Treatment Outcome | 2007 |
Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk.
Topics: Biomarkers; C-Reactive Protein; Cholesterol, HDL; Creatinine; Female; Fibrinogen; Humans; Intercellular Adhesion Molecule-1; Lipoprotein(a); Middle Aged; Multivariate Analysis; Peripheral Vascular Diseases; Prospective Studies; Risk Assessment | 2008 |
Relationship of periodontal attachment loss to peripheral vascular disease: an analysis of NHANES 1999-2002 data.
Topics: Adult; Aged; C-Reactive Protein; Female; Fibrinogen; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Nutrition Surveys; Odds Ratio; Periodontal Attachment Loss; Peripheral Vascular Diseases | 2008 |
Association between ankle-brachial index and risk factor profile in patients newly diagnosed with intermittent claudication.
Topics: Aged; Ankle; Brachial Artery; C-Reactive Protein; Cholesterol, LDL; Creatinine; Cross-Sectional Studies; Diabetes Complications; Dyslipidemias; Female; Fibrinogen; Humans; Hypertension; Intermittent Claudication; Linear Models; Male; Middle Aged; Multivariate Analysis; Peripheral Vascular Diseases; Risk Factors; Smoking | 2008 |
Thrombolytic therapy of peripheral arterial occlusion with recombinant staphylokinase.
Topics: Female; Fibrinogen; Fibrinolytic Agents; Humans; Immunoglobulin G; Infusions, Intra-Arterial; Male; Metalloendopeptidases; Middle Aged; Peripheral Vascular Diseases; Pilot Projects; Radiography; Recombinant Proteins; Thromboembolism; Thrombolytic Therapy; Vascular Patency | 1995 |
Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain.
Topics: Acute-Phase Reaction; Arteriosclerosis; Biomarkers; Blood Coagulation; Blood Glucose; Blood Pressure; Blood Proteins; Body Mass Index; C-Reactive Protein; Coronary Disease; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Intracranial Arteriosclerosis; Lipids; Lipoproteins; Male; Middle Aged; Peripheral Vascular Diseases; Plasminogen Activator Inhibitor 1; Prospective Studies; Radiography; Risk Factors; Severity of Illness Index; Smoking | 1995 |
Prevalence of peripheral arterial occlusive disease and associated risk factors in a sample of southern Sardinian population.
Topics: Adult; Aged; Arterial Occlusive Diseases; Diabetes Mellitus; Female; Fibrinogen; Humans; Hyperlipidemias; Hypertension; Italy; Male; Middle Aged; Obesity; Peripheral Vascular Diseases; Prevalence; Risk Factors; Smoking; Surveys and Questionnaires | 1994 |
Severity of peripheral atherosclerosis is associated with fibrinogen and degradation of cross-linked fibrin.
Topics: Adult; Aged; Aged, 80 and over; Antithrombin III; Arteriosclerosis; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Fibrinopeptide A; Humans; Male; Middle Aged; Peptide Hydrolases; Peripheral Vascular Diseases; Radiography; Ultrasonography | 1993 |
Smoking, haemostatic factors and lipid peroxides in a population case control study of peripheral arterial disease.
Topics: Aged; Arteriosclerosis; beta-Thromboglobulin; Case-Control Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Lipid Peroxides; Male; Middle Aged; Peripheral Vascular Diseases; Plasminogen Inactivators; Random Allocation; Smoking; von Willebrand Factor | 1993 |
Microalbuminuria is a marker of left ventricular hypertrophy but not hyperinsulinemia in nondiabetic atherosclerotic patients.
Topics: Administration, Oral; Aged; Albuminuria; Angiography; Arteriosclerosis; Blood Glucose; Blood Pressure; C-Peptide; Echocardiography; Fibrinogen; Glucose; Humans; Hyperinsulinism; Hypertrophy, Left Ventricular; Insulin; Lipids; Male; Middle Aged; Peripheral Vascular Diseases | 1993 |
Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study.
Topics: Aged; Arteriosclerosis; Blood Coagulation; Blood Viscosity; Cross-Sectional Studies; Female; Fibrinogen; Humans; Intermittent Claudication; Leukocyte Elastase; Male; Middle Aged; Pancreatic Elastase; Peripheral Vascular Diseases; Scotland | 1993 |
Plasma viscosity increase with progression of peripheral arterial atherosclerotic disease.
Topics: Aged; Aged, 80 and over; alpha-Macroglobulins; Arteriosclerosis; Blood Glucose; Blood Viscosity; Cholesterol; Disease Progression; Female; Fibrinogen; Humans; Intermittent Claudication; Ischemia; Leg; Male; Middle Aged; Peripheral Vascular Diseases; Plasma; Prognosis; Risk Factors | 1996 |
Increased serum laminin and angiogenin concentrations in patients with peripheral arterial occlusive disease.
Topics: Angiogenesis Inducing Agents; Arterial Occlusive Diseases; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Humans; Laminin; Male; Middle Aged; Peripheral Vascular Diseases; Proteins; Ribonuclease, Pancreatic | 1996 |
Increased platelet and coagulatory activity in peripheral atherosclerosis flow mediated platelet function is a sensitive and specific disease indicator.
Topics: Antithrombin III; Arteriosclerosis; Blood Coagulation; Blood Coagulation Tests; Blood Flow Velocity; Blood Platelets; Case-Control Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Peptide Hydrolases; Peripheral Vascular Diseases; Platelet Adhesiveness; Platelet Aggregation; Platelet Function Tests; Sensitivity and Specificity | 1996 |
Fibrinogen and albuminuria are related to the presence and severity of peripheral arterial disease in women with type 2 diabetes mellitus.
Topics: Aged; Albuminuria; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Humans; Lipids; Middle Aged; Peripheral Vascular Diseases; Regression Analysis; Risk Factors | 1997 |
Association of hemostatic factors with peripheral vascular disease.
Topics: Aged; Blood Coagulation Factors; Blood Pressure; Factor VII; Female; Fibrinogen; Hemostasis; Humans; Logistic Models; Male; Middle Aged; Peripheral Vascular Diseases; Plasminogen Activator Inhibitor 1; Risk Factors; von Willebrand Factor | 1997 |
Smoking, hemorheologic factors, and progression of peripheral arterial disease in patients with claudication.
Topics: Blood Viscosity; Disease Progression; Female; Fibrinogen; Hemorheology; Humans; Intermittent Claudication; Ischemia; Leg; Male; Middle Aged; Multivariate Analysis; Peripheral Vascular Diseases; Prognosis; Prospective Studies; Regional Blood Flow; Smoking | 1998 |
Fibrinogen and fibrinolysis in blood and in the arterial wall: its role in advanced atherosclerotic disease.
Topics: Aorta, Abdominal; Aortic Diseases; Arteriosclerosis; Carotid Artery Diseases; Case-Control Studies; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Femoral Artery; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Interleukin-6; Muscle, Smooth, Vascular; Peripheral Vascular Diseases; Plasminogen Activator Inhibitor 1; Popliteal Artery; Risk Factors; Urokinase-Type Plasminogen Activator | 1998 |
Epidemiology of atherosclerotic peripheral arterial occlusive disease in Hong Kong.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Arteriosclerosis; China; Demography; Diabetes Mellitus; Female; Femoral Artery; Fibrinogen; Hong Kong; Humans; Hypercholesterolemia; Hyperglycemia; Hyperlipoproteinemias; Hypertension; Hypertriglyceridemia; Ischemia; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Peripheral Vascular Diseases; Popliteal Artery; Prevalence; Prospective Studies; Risk Factors; Sex Factors; Smoking | 1999 |
Fibrinogen, factor VII and PAI-1 genotypes and the risk of coronary and peripheral atherosclerosis: Edinburgh Artery Study.
Topics: Aged; Alleles; Arteriosclerosis; Coronary Artery Disease; Cross-Sectional Studies; Factor VII; Female; Fibrinogen; Follow-Up Studies; Genotype; Humans; Male; Middle Aged; Peripheral Vascular Diseases; Plasminogen Activator Inhibitor 1; Polymerase Chain Reaction; Polymorphism, Genetic; Prospective Studies; Risk Factors; Smoking | 1999 |
Influence of systemic factors on pre-existing intimal hyperplasia and their effect on the outcome of infrainguinal arterial reconstruction with vein.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Blood Vessel Prosthesis Implantation; Female; Fibrinogen; Graft Rejection; Graft Survival; Homocysteine; Humans; Hyperplasia; Lipoprotein(a); Male; Middle Aged; Peripheral Vascular Diseases; Plastic Surgery Procedures; Saphenous Vein; Treatment Outcome; Tunica Intima | 1999 |
Plasma fibrinogen, haemostatic factors and prediction of peripheral arterial disease in the Edinburgh Artery Study.
Topics: Aged; Antifibrinolytic Agents; Antigens; Biomarkers; Blood Coagulation Factors; Cohort Studies; Disease Progression; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Ischemia; Male; Middle Aged; Peripheral Vascular Diseases; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Factors; Surveys and Questionnaires; Tissue Plasminogen Activator; Urban Population; von Willebrand Factor | 2000 |
Mechanism underlying increased platelet reactivity in patients with peripheral arterial disease.
Topics: Anticoagulants; Aspirin; Blood Platelets; Fibrinogen; Heparin; Humans; Peripheral Vascular Diseases; Platelet Adhesiveness | 1999 |
Serum vitamin C concentration is low in peripheral arterial disease and is associated with inflammation and severity of atherosclerosis.
Topics: Aged; Arteriosclerosis; Ascorbic Acid; Aspirin; C-Reactive Protein; Female; Fibrinogen; Humans; Hypertension; Inflammation; Lipids; Male; Middle Aged; Multivariate Analysis; Peripheral Vascular Diseases; Severity of Illness Index; Smoking | 2001 |
Plasma fibrinogen in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction.
Topics: Adult; Aged; Angina Pectoris; Arterial Occlusive Diseases; Arteriosclerosis; Cerebrovascular Disorders; Cross-Sectional Studies; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Peripheral Vascular Diseases; Retrospective Studies; Severity of Illness Index | 2001 |
Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease.
Topics: Adult; Aged; Apolipoproteins; Arteriosclerosis; Biomarkers; C-Reactive Protein; Case-Control Studies; Cholesterol; Fibrinogen; Homocysteine; Humans; Likelihood Functions; Lipoprotein(a); Male; Middle Aged; Peripheral Vascular Diseases; Predictive Value of Tests; Prospective Studies; Regression Analysis; Risk Factors; Statistics, Nonparametric | 2001 |
[Novel risk factors for atherosclerosis. A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a) and cholesterol as predictors of peripheral arteriopathy].
Topics: Arteriosclerosis; Biomarkers; C-Reactive Protein; Cholesterol; Fibrinogen; Homocysteine; Humans; Lipoprotein(a); Peripheral Vascular Diseases; Risk Factors | 2001 |
Balloon angioplasty and stent implantation induce a vascular inflammatory reaction.
Topics: Aged; Angiography; Angioplasty, Balloon; C-Reactive Protein; Case-Control Studies; Chi-Square Distribution; Cohort Studies; Female; Fibrinogen; Humans; Inflammation Mediators; Leukocyte Count; Logistic Models; Male; Middle Aged; Peripheral Vascular Diseases; Probability; Prognosis; Prospective Studies; Reference Values; Sensitivity and Specificity; Serum Amyloid A Protein; Severity of Illness Index; Stents; Vasculitis | 2002 |
Fibrinogen genotype and risk of peripheral atherosclerosis.
Topics: Aged; Alleles; Arteriosclerosis; Case-Control Studies; Chromosome Mapping; Female; Fibrinogen; Gene Frequency; Genotype; Haplotypes; Humans; Male; Middle Aged; Peripheral Vascular Diseases; Risk Factors; Smoking | 1992 |
Fibrinogen genes and peripheral arterial disease.
Topics: Case-Control Studies; Fibrinogen; Gene Frequency; Humans; Peripheral Vascular Diseases; Selection Bias | 1992 |